Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

APAC set to emerge as epicenter for artificial intelligence growth, says GlobalData

Supportive government framework and policies are expected to enable the Asia-Pacific (APAC) region to emerge as the global epicenter for the growth of artificial intelligence (AI), says GlobalData, a leading data and analytics company. Several countries across the region are focusing on leveraging AI, enhancing productivity and competitiveness. Though the key objectives of different government […]
Read more

China to lead global automotive market recovery, says GlobalData

Following the news that major OEMs in China witnessed strong year-on-year growth in vehicle sales volume in May 2020; Animesh Kumar, Director of Automotive Consulting at GlobalData, a leading research and consulting company, offers his view: “China automotive market was the first to be hit by COVID-19 pandemic. As per China Association of Automobile Manufacturers […]
Read more

Cloud-based offerings outshine traditional products amid current COVID-19 scenario in APAC, says GlobalData

The COVID-19 pandemic has accelerated the demand for digital technologies to ensure resilient enterprise business operations. Subsequently, a surge in demand across the Asia-Pacific (APAC) region has resulted in cloud-based offerings outshining traditional products, says GlobalData, a leading data and analytics company. Anshuma Singh, Technology Analyst at GlobalData, comments: “Key verticals like banking and financial, […]
Read more

Use of real-world data for medical device approval significantly reduces time to market in China, says GlobalData

The National Medical Products Administration (NMPA) of China has recently expanded the list of medical devices exempted from providing locally generated clinical trial data and allowed the use of real-world data for medical device registration. These steps will encourage foreign medical device manufacturers to access the Chinese market as the new process will reduce registration […]
Read more

Big tech companies bet on digital platforms to successfully steer through COVID-19 crisis, says GlobalData

Despite the COVID-19 crisis, tech giants Facebook, Apple, Microsoft, Google and Amazon (FAMGA) have reported revenue growth in the first quarter (Q1) of 2020 even while small and medium enterprises struggled to navigate through the difficult times. Given that consumers would continue to spend more time online during the pandemic-induced lockdown in some form through […]
Read more

Repurposing product offerings for business continuity and digital transformation vital for technology vendors in APAC, says GlobalData

The current COVID-19 pandemic will eventually result in an increased transition towards digitalization, with enterprises working towards reducing risks and ensuring business continuity for their operations. Against this backdrop, technology vendors in the Asia-Pacific (APAC) region with new product propositions for business continuity can make a faster recovery, says GlobalData, a leading data and analytics […]
Read more

Mammography equipment market in APAC to grow at robust CAGR of 25.1% between 2019 and 2028, forecasts GlobalData

The mammography equipment market in the Asia-Pacific (APAC) region is expected to grow at a compound annual growth rate (CAGR) of 25.1% from US$0.6bn in 2019 to US$4.2bn by 2028, according to GlobalData, a leading data, and analytics company. GlobalData’s report, ‘Mammography Equipment – Diagnostic Imaging Market Analysis and Forecast Model’ states that while inclination […]
Read more

Local production of APIs in India for COVID-19 repurposed drugs likely to offer competitive advantage, says GlobalData

The local production of the active pharmaceutical ingredients (API) for some of the key COVID-19 repurposed drugs including remdesivir, favipiravir and hydroxychloroquine (HCQ) is likely to offer a competitive advantage for the formulations manufactured in India in terms of supply and price, says GlobalData, a leading data and analytics company. According to GlobalData’s COVID-19 Executive […]
Read more

India’s Sun Pharma bets on another repurposed drug research for COVID-19 cure, says GlobalData

Following the news that India-based Sun Pharmaceutical Industries Ltd (Sun Pharma) has received Indian regulatory approval to start clinical trials of pancreatitis drug nafamostat mesylate in COVID-19 patients; Prashant Khadayate, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view: “Sun Pharma being the leading player in India seems to be slightly […]
Read more

Launch of dasatinib generics will be huge financial upside for CML patients in India, says GlobalData

The launch of the generic versions of dasatinib, following the expiration of Indian patent in April 2020 will increase the accessibility for treatment of chronic myeloid leukemia (CML)  and acute lymphoblastic leukemia (ALL) and subsequently result in huge cost savings, says GlobalData, a leading data and analytics company. Post patent expiry of BMS’ Sprycel (dasatinib), […]
Read more
1 … 183 184 185 186 187 … 209